Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-09-17
DOI
10.1007/s40257-023-00818-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased sensitivity to touch‐evoked itch (punctate hyperknesis) in prurigo nodularis and type 2 inflammation: a cross‐sectional pilot study
- (2023) Takashi Hashimoto et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Cost-effectiveness and Quality of Specialized and Routine Care in a German Cohort of Patients with Chronic Pruritus
- (2023) Svenja Müller et al. ACTA DERMATO-VENEREOLOGICA
- Serum Interleukin-13 and Caspase 8 are Elevated in Prurigo Nodularis
- (2023) Teresa Ju et al. ACTA DERMATO-VENEREOLOGICA
- 436 Nemolizumab monotherapy was associated with significant improvements in prurigo activity score in adult patients with moderate-to-severe prurigo nodularis: results from a phase 3 trial (OLYMPIA 2)
- (2023) Sonja Ständer et al. BRITISH JOURNAL OF DERMATOLOGY
- Prurigo nodularis is highly linked with neural sensitization disorders of pain among hospitalized adults in the United States – National Inpatient Sample 2016–2019
- (2023) Siri Choragudi et al. BRITISH JOURNAL OF DERMATOLOGY
- Failure of Dupilimab With Severe Prurigo Nodularis That Responded Well to Abrocitinib
- (2023) Ashley Vander Does et al. Dermatitis
- Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis
- (2023) Natalia Alkon et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The effectiveness and safety of dupilumab in the management of refractory prurigo nodularis in 45 Chinese patients: A real‐life observational study
- (2023) Hao‐Yue Fang et al. JOURNAL OF DERMATOLOGY
- Transcriptomic landscape of prurigo nodularis lesional skin CD3+ T cells using single-cell RNA-Sequencing
- (2023) Andreea Calugareanu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A polygenic risk score for predicting racial and genetic susceptibility to prurigo nodularis
- (2023) Chirag Vasavda et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study
- (2023) Elena Pezzolo et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The blood proteomic signature of prurigo nodularis reveals distinct inflammatory and neuropathic endotypes: A cluster analysis
- (2023) Varsha Parthasarathy et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
- (2023) Gil Yosipovitch et al. NATURE MEDICINE
- Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study
- (2023) Howard Sofen et al. EClinicalMedicine
- Myeloid dendritic cells are increased in the lesional skin and associated with pruritus in patients with prurigo nodularis
- (2023) Taoming Liu et al. MedComm
- Chronic prurigo
- (2022) Laurent Misery BRITISH JOURNAL OF DERMATOLOGY
- Cutaneous Transcriptomics Identifies Fibroproliferative and Neurovascular Gene Dysregulation in Prurigo Nodularis Compared with Psoriasis and Atopic Dermatitis
- (2022) Nishadh Sutaria et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)
- (2022) Vivian Y. Shi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Nemolizumab: First Approval
- (2022) Susan J. Keam DRUGS
- Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances
- (2022) S. Ständer et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- RNA sequencing reveals the transcriptome profile of the atopic prurigo nodularis with severe itching
- (2022) Yixin Shao et al. EXPERIMENTAL DERMATOLOGY
- Transcriptomic, Epigenomic, and Neuroanatomic Signatures Differ in Chronic Prurigo, Atopic Dermatitis, and Brachioradial Pruritus
- (2022) Konstantin Agelopoulos et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
- (2022) David Rosmarin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
- (2022) Dorothea Terhorst‐Molawi et al. ALLERGY
- Successful treatment of prurigo nodularis with tofacitinib: The experience from a single center
- (2022) Taoming Liu et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Circulating plasma IL-13 and periostin are dysregulated type 2 inflammatory biomarkers in prurigo nodularis: A cluster analysis
- (2022) Varsha Parthasarathy et al. Frontiers in Medicine
- Extracellular matrix and dermal nerve growth factor dysregulation in prurigo nodularis compared to atopic dermatitis
- (2022) Junwen Deng et al. Frontiers in Medicine
- Itch intensity in prurigo nodularis is closely related with dermal interleukin‐31, oncostatin M, IL‐31 receptor alpha, and oncostatin M receptor beta
- (2021) Takashi Hashimoto et al. EXPERIMENTAL DERMATOLOGY
- Pruritus Intensity Scales across Europe: A Prospective Validation Study
- (2021) M. Storck et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Interleukin‐31: The ‘itchy’ cytokine in inflammation and therapy
- (2021) Angeliki Datsi et al. ALLERGY
- Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies
- (2021) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Prevalence, incidence and presence of comorbidities in patients with prurigo and pruritus in Germany: A population‐based claims data analysis
- (2021) M. Augustin et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Chronic Prurigo: Similar Clinical Profile and Burden Across Clinical Phenotypes
- (2021) Claudia Zeidler et al. Frontiers in Medicine
- Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab
- (2021) Lam C. Tsoi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cluster Analysis of Circulating Plasma Biomarkers in Prurigo Nodularis Reveals a Distinct Systemic Inflammatory Signature in African Americans
- (2021) Nishadh Sutaria et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open‐label extension phase
- (2021) E. Weisshaar et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- One third of Chronic Prurigo patients scratch automatically and in the absence of itch – a naturalistic study of 1142 patients
- (2021) G. Schneider et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors
- (2021) Chisa Nakashima et al. ALLERGOLOGY INTERNATIONAL
- Chronic Nodular Prurigo: Clinical Profile and Burden. A European Cross‐sectional Study
- (2020) M.P. Pereira et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis
- (2020) Sonja Ständer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prurigo Nodularis: Pathogenesis and Management
- (2020) Kyle A. Williams et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
- (2020) Eric L Simpson et al. LANCET
- The burden in chronic prurigo: patients with chronic prurigo suffer more than patients with chronic pruritus on non‐lesional skin
- (2020) C. Zeidler et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response
- (2020) Husein Husein-ElAhmed et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Dupilumab for pediatric prurigo nodularis: A case report
- (2020) Tahel Fachler et al. PEDIATRIC DERMATOLOGY
- Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis
- (2020) Kyle A. Williams et al. Expert Review of Clinical Pharmacology
- Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial
- (2019) Sonja Ständer et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- How to define chronic pruritus – symptom or disease?
- (2019) Sonja Ständer EXPERIMENTAL DERMATOLOGY
- Peripheral sensitisation and loss of descending inhibition is a hallmark of chronic pruritus
- (2019) Esther M. Pogatzki-Zahn et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Diagnostic and Treatment Algorithm for Chronic Nodular Prurigo
- (2019) Hartmut F. Ständer et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Real-world prevalence of prurigo nodularis and burden of associated diseases
- (2019) Amy H. Huang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Ethnic differences and comorbidities of 909 Prurigo Nodularis patients
- (2018) Emily Boozalis et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Prurigo Activity Score (PAS): validity and reliability of a new instrument to monitor chronic prurigo
- (2018) J. Pölking et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The self-assessed psychological comorbidities of prurigo in European patients: a multicentre study in 13 countries
- (2018) E. Brenaut et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Position Statement: Linear prurigo is a subtype of chronic prurigo
- (2018) M.P. Pereira et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- There is no functional small-fibre neuropathy in prurigo nodularis despite neuroanatomical alterations
- (2017) Manuel P. Pereira et al. EXPERIMENTAL DERMATOLOGY
- JAK inhibitors in dermatology: The promise of a new drug class
- (2017) William Damsky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo
- (2017) M.P. Pereira et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Stigma – Risikofaktor und Konsequenz suizidalen Verhaltens
- (2017) N. Oexle et al. NERVENARZT
- Intraepidermal Nerve Fibre Density is Decreased in Lesional and Inter-lesional Prurigo Nodularis and Reconstitutes on Healing of Lesions
- (2016) S Bobko et al. ACTA DERMATO-VENEREOLOGICA
- Anxiety, depression and suicide in patients with prurigo nodularis
- (2016) K.M. Jørgensen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Relations between the characteristics and psychological comorbidities of chronic pruritus differ between men and women: women are more anxious than men
- (2015) A. Stumpf et al. BRITISH JOURNAL OF DERMATOLOGY
- The pathogenesis of Prurigo nodularis - ‘Super-Itch’ in exploration
- (2015) C. Zeidler et al. EUROPEAN JOURNAL OF PAIN
- Nihil certum: Historische Entwicklung des Begriffs Prurigo
- (2014) C.M. Schürmann et al. HAUTARZT
- Evaluation of the Antipruritic Effects of Topical Pimecrolimus in Non-Atopic Prurigo Nodularis: Results of a Randomized, Hydrocortisone-Controlled, Double-Blind Phase II Trial
- (2013) Dorothee Siepmann et al. DERMATOLOGY
- Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathy
- (2011) B. Schuhknecht et al. BRITISH JOURNAL OF DERMATOLOGY
- A pilot quality-of-life instrument for pruritus
- (2008) Nisha S. Desai et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now